Nawe, Diaser .

HRN: 22-11-85  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2022
CEFUROXIME 750MG (VIAL)
10/27/2022
11/03/2022
IV
400mg
Q8h
Pcap C
Waiting Final Action 
10/27/2022
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
10/27/2022
10/31/2022
PO
5 Ml
Q12
Intestinal Parasitism
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: